NASDAQ: SIBN - Si-Bone Inc

Rentabilité sur six mois: -5.72%
Rendement en dividendes: 0.00%

Calendrier des promotions Si-Bone Inc

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Si-Bone Inc

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.

plus de détails
The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2018-10-17
ISIN US8257041090
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://si-bone.com
Цена ао 13.81
Changement de prix par jour: +5.99% (13.85)
Changement de prix par semaine: +9.72% (13.38)
Changement de prix par mois: -9.72% (16.26)
Changement de prix sur 3 mois: +12.58% (13.04)
Changement de prix sur six mois: -5.72% (15.57)
Changement de prix par an: -30.79% (21.21)
Evolution du prix sur 3 ans: -33.42% (22.05)
Evolution du prix sur 5 ans: -18.35% (17.98)
Evolution des prix sur 10 ans: 0% (14.68)
Evolution des prix depuis le début de l'année: -8.59% (16.06)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficacité

Nom Signification Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA 0 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 106.37 10
Rentabilité Ebitda, % 24.06 4
Rentabilité EPS, % -26.45 0
Total: 3
Plus de détails

Superviseur Titre d'emploi Paiement Année de naissance
Ms. Laura A. Francis MBA CEO & Director 1967 (58 années)
Mr. Anshul Maheshwari Chief Financial Officer 1980 (45 années)
Mr. Anthony J. Recupero President of Commercial Operations 1959 (66 années)
Mr. Jeff Bertolini Senior Vice President of Operations & Information Technology
Dr. Scott A. Yerby Senior VP of Engineering & CTO 1968 (57 années)
Saqib Iqbal Director of FP&A and Investor Relations
Mr. Michael A. Pisetsky Chief Business & Legal Affairs Officer, Secretary and General Counsel 1978 (47 années)
Ms. Aimee Einstein Vice President of People & Culture
Dr. Daniel Joseph Cher Senior Vice President of Clinical & Regulatory Affairs 1965 (60 années)
Dr. W. Carlton Reckling Chief Medical Officer & VP of Medical Affairs 1962 (63 année)

Adresse: United States, Santa Clara, 471 El Camino Real - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://si-bone.com